L. Kristin Newby, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: CSL(MODEST), Medtronic(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Roche Diagnostics(SIGNIFICANT), BioKier(MODEST), Medtronic(MODEST) OTHER FINANCIAL BENEFIT: Boehringer Ingelheim Pharmaceuticals, Inc(MODEST)

View Full Disclosure